Singapore Cardiac Society 35th Annual Scientific Meeting

Sponsors & Exhibitors

The Singapore Cardiac Society 35th Annual Scientific Meeting (SCS ASM 2024) would like to thank the following sponsors and exhibitors for their support:

PLATINUM LEVEL

Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. More than 52,000 employees serve over 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. 

Our purpose is to discover new ways to improve and extend people’s lives. Our vision is to become the most valued and trusted medicines company in the world.  

Novo Nordisk is a leading global healthcare company established in 1923, with a legacy of over 100 years and a rich heritage in diabetes. Specializing in innovative treatments for diabetes, obesity, and rare blood and endocrine diseases, we are dedicated to addressing unmet medical needs, expanding medicine access, and committed to driving change to defeat serious chronic diseases 

SILVER LEVEL

At Amgen, our mission is to serve patients. We dedicate our days to turning the tide on serious, life-interrupting illnesses—pushing the boundaries of science to transform medicine.

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. 

Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit us at www.bostonscientific.com 

 EXHIBITORS

At Menarini Asia-Pacific, we are dedicated to invigorating lives. Driven by a firm belief that good health empowers people to unlock their full potential, we serve over 13 key markets in the region to enhance healthcare and uplift the lives of people and communities. 
 
Armed with strong commercial capabilities and a flexible business and partnering model, we support customers in a diverse range of therapeutic areas by providing access to health and wellness solutions. The agility of our in-country teams allows us to harness synergies across relevant channels and develop customised go-to-market models. This helps improve the health of underserved patients. 

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 114,000 colleagues serve people in more than 160 countries. 

At Bayer Pharmaceuticals, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies. 

With our innovative products, we seek to achieve therapeutic benefit for patients, while at the same time satisfying the growing requirements of physicians and health insurers. 

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We believe in the power of science to address some of the most challenging diseases of our time. 

Organon, here for her health
At Organon, we are here for her health. Our goal is to be the leading women’s health company in the world by focusing on women’s everyday health needs.

Today, our company has a portfolio of over 60 medicines and products that we deliver to patients in ~140 markets around the world. But we know there is so much we can do to support the health of women. Therefore, we will put women at the center of everything we do, striving to listen and understand her healthcare needs, big and small, to ensure we provide medicines and other products that allow her to live a better and healthier every day.

As one of the world’s premier innovative biopharmaceutical companies, Pfizer collaborates with health care providers, government agencies and local communities to expand access to reliable and affordable health care. Our portfolio of medicines for therapeutic areas include vaccines, oncology, cardiovascular diseases, infectious diseases, immunological disorders, rare diseases and mental health. 

We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. For more information, visit www.sanofi.com. 

Servier is an international and independent pharmaceutical company governed by a non-profit foundation, with headquarters in Suresnes, France. Since opening our first laboratory in 1954, we are committed to therapeutic progress to serve patient needs.  

Today Servier has presence in 150 countries and focuses Oncology, Cardio-metabolism, Neuroscience and Immuno-inflammation. 

 SYMPOSIUM

Transmedic & Abbott HF

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

 CONGRESS LANYARDS

Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit us at www.bostonscientific.com 

 EDUCATIONAL GRANT

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 114,000 colleagues serve people in more than 160 countries. 

We lead global healthcare technology, boldly attacking the most challenging problems. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ people, and our technologies transform the lives of two people every second, every hour, every day. Expect more from us. 

Medtronic. Engineering the extraordinary. 

As a leading medical equipment distributor in Southeast Asia, Transmedic has been the preferred partner for many healthcare institutions, professionals, and principals since 1980. With over 4 decades of experience operating in the complex-product environment, we have expanded our capabilities into more therapeutic areas such as Radiation, Orthopaedic, Cardiac, Ophthalmology, IVD and Interventional Therapies. 

In 2021-2022, Transmedic has been acquired by LifeHealthcare and subsequently, EBOS Group Limited. This strategic partnership has opened many new opportunities and synergies across Australia, New Zealand and Southeast Asia. Together with LifeHealthcare and its entities, the EBOS MedTech division is formed. 

During the same period, we had the opportunity to enter the Ophthalmology space by acquiring another local distributor, Swissmed.